DENARASE® is now directly available at c-LEcta. c-LEcta has taken over the product distribution from Sartorius Stedim Biotech GmbH by the end of 2016 and now sells DENARASE® under the same brand name and in identical package sizes. Furthermore, c-LEcta continues to produce the endonuclease in the same production facilities using its patent protected production process in full compliance with cGMP requirements. This process allows to provide DENARASE® in an outstanding product quality and at low prices.
DENARASE® from Serratia marcenses is a highly active nuclease that is used to remove interfering DNA and RNA from fermentation batches e.g. during the production of vaccines and biopharmaceuticals.
The advantages of DENARASE® are:
+ Animal product free production
+ endotoxin-free production strain
+ high purity and activity
+ compliance with cGMP
If you are interested in testing our DENARASE or if you need further information, please do not hesitate to contact c-LEcta GmbH via denarase@c-lecta.com.
Fraunhofer IZI. Since January 2017, researchers from Immunic GmbH have been working with scientists at the Department of Drug Design and Target Validation of the Fraunhofer IZI in Halle (Saale) on developing new drugs. The aim is the preclinical development of one or several active candidate ingredients for treating chronically inflammatory and autoimmune diseases.
Max Planck Institute. In violent intergroup conflicts between chimpanzee groups the hormone oxytocin enhances the social affiliation among members of the same group. The high costs of individuals going to war is perplexing. Individuals are willing to suffer costs in order to benefit their own group, through cooperating and supporting their fellow group members and acting with hostility towards the out-group.